Archive for May, 2009

30
May

Congenital Infections

Posted by Jammy B. | No Comments

Pregnant women have a lot of infections and fortunately only a few of those affect the fetus. A number of years ago – actually many many years ago – we did a study and just in a six week period 30% of the women had some infectious illness during that time. So fortunately most of these aren’t transmitted to the fetus. The thing that bothers me is that a lot of the workup of what are likely congenital infections is either not done or done poorly. Epidemiologic aspects of infections are overlooked, and serologic tests are used inappropriately to make diagnoses. Or, more frequently they are done and you will see on the record TORCH titers done. Negative. And what were done were not adequate to make a diagnosis. So these are what we are going to concentrate on today. The only addition, which I am not going to talk about, would be hepatitis C, which probably should be added to the list although its transmission, compared to hepatitis B, is far less.
Cialis professional
The pathogenesis of congenital infections; there are a number of possibilities and the first is that the pregnant woman is infected and transmission to the fetus can be either by the blood, by the placenta, or occasionally ascending infections – frequently with ruptured membranes or leakage of membranes – and then ascending infection, but by and large most of what we will talk about will be by bacteremia or viremia and then via the placenta. The in utero fetus; several things can happen. There can be abortion or stillbirth, can be a one-hit affair, and that is resulting in congenital defects but no continuing infection. Clinical infection which persists throughout pregnancy and involves the infant, there can be asymptomatic infection with recovery. Actually with enteroviruses that happens literally every summer. The infant, as a result of infection, can have acute death, can have persistent infection with manifestations and recovery of infection. Then the child can have late death, late sequelae, or eventual recovery from the infection.
Pheromone cologne for men
What I’ll do now is go through the individual infectious illnesses. The first is CMV and this, actually as far as frequency of major problems, is the most frequent. There are two events. One is perinatally acquired infection, which is exceedingly common but not too important as far as damage to the baby. Then congenital acquisition which occurs in 0.5 to 2.7% of births. But this results by and large from primary infection in the mother and some 50-90% of women have been previously infected. So even though they may have recurrent CMV infections – and some of them will transmit virus in utero – but by and large infections in those babies don’t result in difficulties. The mothers who are infected shed virus in the urine or cervix very commonly, up to 28%. The infection rate of young adults is about 3% per year but for some reason, pregnant women seem to be more susceptible so it can be anywhere from 3-19% of seronegatives during pregnancy have infection and become seropositive. Fetal infection occurs in 50% of primary maternal infections. Damage to the infant occurs in 10-20% of these in utero infections; primarily primary infections, although there are rare cases of apparent damage with infections in mothers who didn’t have primary infection.
Canadian viagra

07
May

Treatment for autism

Posted by Jammy B. | No Comments

FENFLURAMINE
Viagra super active
The finding of hyperserotonemia in one third of autistic children led to the hypothesis that autistic symptoms may be due to increased brain serotonin levels. That hypothesis in turn led to the study of fenfluramine, a serotonin depleter, in autistic children. In several studies fenfluramine was reported to decrease stereotypies and hyperactivity, increase intellectual functioning, foster language development, and improve social relatedness. However, those studies had serious methodological flaws. One well-designed double-blind, placebo-controlled study with random assignment of children having a narrow age range and which assessed cognition in a learning laboratory failed to show a difference for fenfluramine (optimal daily dosage range, 1.250 to 2.068 mg/kg) over placebo in reducing problem behaviors; learning was adversely affected by fenfluramine.

NALTREXONE

Similarities between the behaviors of autistic children and the behaviors of opiate addicts while intoxicated and during withdrawal led to the theory of opioid dysregulation in autism. Case reports and open trials involving a small number of children suggested that naltrexone, an opioid antagonist, reduced stereotypies, withdrawal, and hyperactivity and increased language production. In a recently completed double-blind, placebo-controlled study of naltrexone, the only significant finding in 41 autistic children, aged 2.9 to 7.8 years, who received dosages of 0.5 to 1.0 mg/kg a day of naltrexone was a decrease in hyperactivity; naltrexone had no adverse effect on learning in the laboratory, and the side effects of drowsiness, nausea, and vomiting were mild and transient. There was a suggestion that naltrexone might decrease self-injurious behavior.

SYMPATHOMIMETICS

The efficacy of amphetamines was investigated in autistic children because hyperactivity and inattention, frequently seen in such children, are ameliorated by amphetamines in nonautistic children with attention-deficit/hyperactivity disorder. Early studies of a large number of autistic children reported decreases in hyperactivity and increases in attention span, although severe behavioral toxicity and worsening of stereotypies were also observed. More recently, an open trial of methylphenidate (Ritalin) (optimal daily dose range, 10.0 to 50.0 mg) in nine autistic children resulted in a marked decrease in hyperactivity without major side effects.

CLOMIPRAMINE

Clomipramine (Anafranil online), an antidepressant, inhibits the reuptake of serotonin, which has been implicated in the pathogenesis of autistic disorder. A recent double-blind, placebo-controlled crossover study found clomipramine to be superior to both desipramine (Norpramin) and placebo in decreasing obsessive-compulsive symptoms, anger, and core autistic symptoms, including withdrawal and abnormal object relations. The sample consisted of 7 autistic individuals aged 6 to 18 years. The mean dosage of clomipramine was 129 mg a day (4.3 mg/kg a day). However, in a recent pilot study conducted on eight hospitalized children, aged 3.5 to 8.7 years, clomipramine yielded therapeutic changes in only one child. Untoward effects were numerous and included acute urine retention, constipation, and behavioral effects indicating toxicity; the daily dosage ranged from 2.50 to 4.64 mg/kg (mean, 3.14 mg/kg a day).

CLONIDINE

The possibility that some symptoms of autism reflect hyperarousal and dysregulation of the adrenergic system led to the study of clonidine (Catapres), an alpha2 -adrenergic agonist that reduces noradrenergic activity. In one recent double-blind, placebo-controlled study, clonidine was found to be superior to placebo in decreasing certain problem behaviors. The transdermal administration of clonidine at a mean dosage of 0.005 mg/kg a day was associated with a decrease in stereotypies, withdrawal, hyperactivity, and temper outbursts in nine autistic male patients aged 5 to 33 years. A second double-blind, placebo-controlled study on eight autistic boys aged 5 to 13 years who were hyperactive and impulsive found modest decreases in teacher and parent ratings of hyperactivity and irritability; clinicians’ ratings, however, failed to support an effect for clonidine.

The efficacy of various other psychopharmacological agents, including buspirone (BuSpar online), propranolol (Inderal), and fluoxetine, in a few autistic persons has been reported.